The study is aimed to determine whether the AXONIC-REVIVE™ multimodal strategy resulted in measurable neural recovery following spinal cord injury, as assessed by a combination of functional parameters, neuroimaging data and laboratory markers. The study was conducted at the Faculty of Medicine of the University of Medicine and Social Sciences (Kharkiv) from 3 March to 31 December 2025, where the effectiveness of the applied strategy following spinal cord injury was assessed based on changes in the motor and sensory deficits, muscle tone, functional independence, as well as changes in the electrophysiological indicators of neuromuscular transmission and reinnervation, diffusion tensor magnetic resonance imaging (DTI-МРТ) parameters of the conduction pathways, and concentrations of cerebrospinal fluid biomarkers of neurotrophic support, plasticity and glial response. The results showed that, by week 24, recovery was observed in both groups; however, it was more pronounced in the AXONIC-REVIVE™ group: the motor score increased by 18.6 points versus 11.2, the sensory score by 19.7 versus 11.0, spasticity decreased by 0.8 points compared to 0.3, functional independence increased by 20.7 points compared to 12.1, and an improved bladder control by week 24 was recorded in 57.1% of the patients in the main group compared to 32.1% in the control group. More favourable trends were also observed in electromyography (EMG) (F-wave latency decreased by 5.5 ms compared with 2.4 ms in the control group), diffusion tensor magnetic resonance imaging (fractional anisotropy increased by 0.09 versus 0.04) and cerebrospinal fluid biomarkers of neurotrophic support and plasticity compared with standard rehabilitation overall. Thus, up to week 24, the AXONIC-REVIVE™ multimodal strategy was associated with greater clinical and functional improvement compared with standard rehabilitation. The results obtained can be used by neurosurgeons, physiatrists and multidisciplinary teams in rehabilitation centres to justify comprehensive monitoring and the selection of combined approaches to neurorehabilitation following spinal cord injury in clinical practice and pilot protocols.
World Health Organization. Spinal cord injury [Internet]. 2024. https://www.who.int/news-room/fact-sheets/detail/spinal-cord-injury
Ferrara UP, Tortora C, Rosano C, Assunto A, Rossi A, Pagano S, et al. Bone metabolism in patients with type 1 neurofibromatosis: key role of sun exposure and physical activity. Sci Rep. 2022;12(1):4368. doi:10.1038/s41598-022-07855-4
Zaika V, Tytarenko Ya. A review of the therapeutic and neuroprotective properties of ketamine. Med Sci Ukr. 2026;22(2):170-177. doi:10.32345/2664-4738.2.2026.18
Sagymbayev M, Koichubekov A, Rahmanov B, Nurzhan uulu U. Recovery treatment in the intermediate and late periods of spinal cord injury. Eurasian Health J. 2024;16(4):168-172. doi:10.54890/1694-8882-2024-4- 168
Głowacka A, Ji B, Szczepankiewicz AA, Skup M, Gajewska-Woźniak O. BDNF spinal overexpression after spinal cord injury partially protects soleus neuromuscular junction from disintegration, increasing VAChT and AChE transcripts in soleus but not tibialis anterior motoneurons. Biomedicines. 2022;10(11):2851. doi:10.3390/biomedicines10112851
Suszyński K, Białoń N, Marcol W, Górka D, Górka M. The influence of reinnervation on the results of peripheral nerve repair after injuries. Advances in Hygiene and Experimental Medicine. 2023;77(1):118-124. doi:10.2478/ahem-2023-0012
Nowacka A, Śniegocki M, Ziółkowska E. A review of the potential use of antioxidants in spinal cord injuries. Antioxidants (Basel). 2025;14(9):1081. doi:10.3390/antiox14091081
Pedrini FA, Boriani F, Bolognesi F, Fazio N, Marchetti C, Baldini N. Cell-enhanced acellular nerve allografts for peripheral nerve reconstruction: A systematic review and a meta-analysis of the literature. Neurosurgery. 2019;85(5):575-604. doi:10.1093/neuros/nyy374
Serra PL, Boriani F, Khan U, Atzeni M, Figus A. Rate of free flap failure and return to the operating room in lower limb reconstruction: A systematic review. J Clin Med. 2024;13(15):4295. doi:10.3390/jcm13154295
Yrysov K, Tashibekov J, Baktybek uulu M, Kazyev A. Results of diagnosis and surgical treatment of spinal cord injury. Eurasian Health J. 2024;16(3):163-171. doi:10.54890/1694-8882-2024-3-163
Niemczyk-Soczynska B, Zaszczyńska A, Zabielski K, Sajkiewicz P. Hydrogel, electrospun and composite materials for bone/cartilage and neural tissue engineering. Materials (Basel). 2021;14(22):6899. doi:10.3390/ma14226899
Basiaga B, Baczkowski S, Żądecka-Kobiałka K, Putra A, Marchaj M, Nowicka-Jasińska M, et al. The current state of stem cell therapy for spinal cord injury and other systemic injuries. Archiv EuroMedica. 2024;14(2). doi:10.35630/2024/14/2.207
Głowacka A. Stimulation of neuronal overproduction of BDNF in the injured rat spinal cord: evaluation of molecular and morphological changes during the period of greatest functional improvement. Doctoral dissertation. Nencki Institute of Experimental Biology PAS; 2023. http://rcin.org.pl/ibd/Content/241160/WA488_277578_20304_Glowacka-Anna-2023.pdf
Latka K, Kozlowska K, Waligora M, Kolodziej W, Latka D. Effect of DiscoGel treatment of the intervertebral disc at MRI. Clin Radiol. 2023;78(12):928-934. doi:10.1016/j.crad.2023.07.023
Moffa S, Perna A, Cattolico A, Sellitto C, Ascione A, Tafuri D, et al. Evaluations of muscular strength, ability to balance and health status in prisoners during covid-19. Int J Envir Res Public Health. 2021;18(8):4316. doi:10.3390/ijerph18084316
Efremov A. Integration of AI and Neuroscience: New Methods in Studying the Causes of Mental Disorders. Int J Psychiatry Med. 2026;61(4):498-514. doi:10.1177/00912174261428872
Khramtsov DM, Stoyanov O, Hruzevskiy O, Shevchuk HYu. Complex neurorehabilitation of post-stroke patients. Med Sci Ukr. 2022;18(3):52-59. doi:10.32345/2664-4738.3.2022.08
Zimny A, Podgórski P, Machaj W, Fortuna W, Huber J, Bobek-Billewicz B, et al. Diffusion tensor imaging findings in cerebral sensorimotor areas in patients after spinal cord injury correlate with neurophysiological deficits. Neurorehabil Neural Repair. 2025;39(9):701-714. doi:10.1177/15459683251345434
Huber J, Leszczyńska K, Wincek A, Szymankiewicz-Szukała A, Fortuna W, Okurowski S, et al. The role of peripheral nerve electrotherapy in functional recovery of muscle motor units in patients after incomplete spinal cord injury. Appl Sci. 2021;11(20):9764. doi:10.3390/app11209764
Waliullah S, Singh A, Rastogi D, Kumar D, Kumar A, Sharma AC, et al. Serum Nogo-A as a predictor of neurological recovery in spinal cord injury. Bioinformation. 2025;21(9):3387-3390. doi:10.6026/973206300213387
International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI/ASIA): worksheet and classification materials [Internet]. https://pdmu.edu.ua/storage/ft_nnmi_zo/docs/sHa8biST8guL62YaR89qbFK98GzuOLwTopXe35l9.pdf
Shirley Ryan AbilityLab. Modified Ashworth Scale (MAS) instructions [Internet]. 2026. https://www.sralab.org/sites/default/files/2017-06/Modified%20Ashworth%20Scale%20Instructions.pdf
Shirley Ryan AbilityLab. Spinal Cord Independence Measure (SCIM III) [Internet]. 2026. https://www.sralab.org/sites/default/files/2017-07/SCIM.pdf
World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects [Internet]. 2024. https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/
European Medicines Agency. ICH E6(R2) Good clinical practice: scientific guideline [Internet]. 2025. https://www.ema.europa.eu/en/ich-e6-good-clinical-practice-scientific-guideline
Tuszynski MH, Steward O. Concepts and methods for the study of axonal regeneration in the CNS. Neuron. 2012;74(5):777-791. doi:10.1016/j.neuron.2012.05.006
Kaniuk JK, Kumar D, Tennyson J, Hurka KL, Margolis A, Bucaloiu A, et al. Spinal cord injury remyelination: pathways to therapies. Int J Mol Sci. 2025;26(15):7249. doi:10.3390/ijms26157249
Hirt J, Khanteymoori A, Hohenhaus M, Kopp MA, Howells DW, Schwab JM, et al. Inhibition of the Nogo-pathway in experimental spinal cord injury: a meta-analysis of 76 experimental treatments. Sci Rep. 2023;13:22898. doi:10.1038/s41598-023-49260-5
Yadav S, Mukherjee S. Pathophysiology of spinal cord injury and advanced therapeutic approaches. Mol Biol Rep. 2025;52(1):669. doi:10.1007/s11033-025-10785-9
Zhai T, Ren S, Qian S, Shi C, Wang B, Zhang C, et al. Exercise training promotes nerve cell repair and regeneration after spinal cord injury. Neural Regen Res. 2026;21(6):2153-2168. doi:10.4103/nrr.nrr-d-24-01677
Fournier AE, Takizawa BT, Strittmatter SM. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci. 2003;23(4):1416-1423. doi:10.1523/JNEUROSCI.23-04-01416.2003
Khavandegar A, Ahmadi NS, Mousavi MA, Ramezani Z, Khodadoust E, Hasan Zadeh Tabatabaei MS, et al. The potential role of RhoA/ROCK-inhibition on locomotor recovery after spinal cord injury: a systematic review of in-vivo studies. Spinal Cord. 2025;63(3):95-126. doi:10.1038/s41393-025-01064-2
Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN, et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature. 2002;416(6881):636-640. doi:10.1038/416636a
Schwab ME. Functions of Nogo proteins and their receptors in the nervous system. Nat Rev Neurosci. 2010;11(12):799-811. doi:10.1038/nrn2936
Simis M, Doruk Camsari D, Imamura M, Filippo TRM, Rubio De Souza D, Battistella LR, et al. Electroencephalography as a biomarker for functional recovery in spinal cord injury patients. Front Hum Neurosci. 2021;15:548558. doi:10.3389/fnhum.2021.548558
Feng T, Zhao C, Su WN, Gao YM, Wu YY, Zhao W, et al. Longitudinal changes in brain network metrics and their correlations with spinal cord diffusion tensor imaging parameters following spinal cord injury and regenerative therapy. Biomedicines. 2025;13(12):3124. doi:10.3390/biomedicines13123124
Wen Z, Song L, Liu P, Chin ATZE, Zhou W, Hu Q. A laminin-mimicking hydrogel as regenerative microenvironment for the repair of peripheral nerve injury. Colloids Surf A Physicochem Eng Asp. 2025;723:137369. doi:10.1016/j.colsurfa.2025.137369
Fang F, Wang X, Tao Y, Su Y, Dan W, Du Z, et al. Collagen-based biomaterials in neural injury repair: current advances and future perspectives. Collagen Leather. 2025;7(1):27. doi:10.1186/s42825-025-00209-6
Rybachuk O, Nesterenko Y, Zhovannyk V. Modern advances in spinal cord regeneration: hydrogel combined with neural stem cells. Front Pharmacol. 2024;15:1419797. doi:10.3389/fphar.2024.1419797
Wei S, Dong J, Hu Q, Bai J, Gao X, Shan H, et al. Advances in mesenchymal stem cells and their derivatives for promoting peripheral nerve regeneration. Burns Trauma. 2025;13:tkaf027. doi:10.1093/burnst/tkaf027
Toader C, Serban M, Munteanu O, Covache-Busuioc RA, Enyedi M, Ciurea AV, et al. From synaptic plasticity to Neurodegeneration: BDNF as a transformative target in medicine. Int J Mol Sci. 2025;26(9):4271. doi:10.3390/ijms26094271
Li Y, Tran A, Graham L, Brock J, Tuszynski MH, Lu P. BDNF guides neural stem cell-derived axons to ventral interneurons and motor neurons after spinal cord injury. Exp Neurol. 2023;359:114259. doi:10.1016/j.expneurol.2022.114259
Talifu Z, Qin C, Xin Z, Chen Y, Liu J, Dangol S, et al. The overexpression of insulin-like growth factor-1 and neurotrophin-3 promote functional recovery and alleviate spasticity after spinal cord injury. Front Neurosci. 2022;16:863793. doi:10.3389/fnins.2022.863793
Cunha RS, Rossi EA, Santana TAD, Costa-Ferro ZSM, Souza BSDF. Chondroitinase ABC in spinal cord injury: advances in delivery strategies and therapeutic synergies. Front Bioeng Biotechnol. 2025;13:1604502. doi:10.3389/fbioe.2025.1604502
Koushki S, Askaripour H, Bahiraee S. Review on strategies for enhancing stability of chondroitinase ABC in the treatment of spinal cord injury. Discov Appl Sci. 2025;7:219. doi:10.1007/s42452-025-06656-4

This work is licensed under a Creative Commons Attribution 4.0 International License.